FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4345811000001100: Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17911501000001112 Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
54996401000001116 Charcodote 200mg/ml oral suspension (Teva UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) Is a Activated charcoal 200mg/ml oral suspension sugar free true Inferred relationship Existential restriction modifier
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) Has active ingredient Activated charcoal true Inferred relationship Existential restriction modifier
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) Is a Charcodote true Inferred relationship Existential restriction modifier
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) Has specific active ingredient Activated charcoal true Inferred relationship Existential restriction modifier
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) Has manufactured dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) 250 ml Is pack of False Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) Inferred relationship Existential restriction modifier
Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) 250 ml Has AMP True Charcodote 200mg/ml oral suspension (Pliva Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start